These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 7506033)

  • 21. Significance of anti-Gal IgG in chronic xenograft rejection.
    Galili U
    Transplant Proc; 1999; 31(1-2):940-1. PubMed ID: 10083416
    [No Abstract]   [Full Text] [Related]  

  • 22. Alpha-galactosyl antibody redistributes alpha-galactosyl at the surface of pig blood and endothelial cells.
    Maruyama S; Cantu E3rd ; Pernis B; Galili U; Godman G; Stern DM; Andres G
    Transpl Immunol; 1999 Jun; 7(2):101-6. PubMed ID: 10544440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xenotransplantation for brain repair: reduction of porcine donor tissue immunogenicity by treatment with anti-Gal antibodies and complement.
    Brevig T; Meyer M; Kristensen T; Zimmer J; Holgersson J
    Transplantation; 2001 Jul; 72(2):190-6. PubMed ID: 11477337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-Gal, alpha-Gal epitopes, and xenotransplantation.
    Kobayashi T; Cooper DK
    Subcell Biochem; 1999; 32():229-57. PubMed ID: 10391998
    [No Abstract]   [Full Text] [Related]  

  • 25. Gal alpha(1,3)Gal is the major xenoepitope expressed on pig endothelial cells recognized by naturally occurring cytotoxic human antibodies.
    Vaughan HA; Loveland BE; Sandrin MS
    Transplantation; 1994 Oct; 58(8):879-82. PubMed ID: 7524207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conformational analysis of an alpha-galactosyl trisaccharide epitope involved in hyperacute rejection upon xenotransplantation.
    Li J; Ksebati MB; Zhang W; Guo Z; Wang J; Yu L; Fang J; Wang PG
    Carbohydr Res; 1999 Jan; 315(1-2):76-88. PubMed ID: 10385973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cloning of anti-Gal Fabs from combinatorial phage display libraries: structural analysis and comparison of Fab expression in pComb3H and pComb8 phage.
    Wang L; Radic MZ; Siegel D; Chang T; Bracy J; Galili U
    Mol Immunol; 1997 Jun; 34(8-9):609-18. PubMed ID: 9393964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reactivity of human anti-alpha-galactosyl IgG antibody with alpha(1-->3)-linked galactosyl epitopes exposed on basement membranes and on glomerular epithelial cells: an in vitro and in vivo study in the mouse.
    Vecchi ML; Davin JC; Castronovo V; Foidart JM; Malaise M; Foidart JB; Dechene C; Sangiorgi GB; Mahieu P
    Clin Exp Immunol; 1989 Nov; 78(2):271-7. PubMed ID: 12412761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of antigen presentation of influenza virus hemagglutinin by the natural human anti-Gal antibody.
    Galili U; Repik PM; Anaraki F; Mozdzanowska K; Washko G; Gerhard W
    Vaccine; 1996 Mar; 14(4):321-8. PubMed ID: 8744560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of α-Gal epitope, anti-Gal antibody, α1,3 galactosyltransferase and its clinical exploitation (Review).
    Huai G; Qi P; Yang H; Wang Y
    Int J Mol Med; 2016 Jan; 37(1):11-20. PubMed ID: 26531137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A possible role for the alpha 1-->3 galactosyl epitope and the natural anti-gal antibody in oncogenesis.
    Gollogly L; Castronovo V
    Neoplasma; 1996; 43(5):285-9. PubMed ID: 8996545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variations in activity of the human natural anti-Gal antibody in young and elderly populations.
    Wang L; Anaraki F; Henion TR; Galili U
    J Gerontol A Biol Sci Med Sci; 1995 Jul; 50(4):M227-33. PubMed ID: 7542151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody.
    Rother RP; Fodor WL; Springhorn JP; Birks CW; Setter E; Sandrin MS; Squinto SP; Rollins SA
    J Exp Med; 1995 Nov; 182(5):1345-55. PubMed ID: 7595205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gal alpha (1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies.
    Sandrin MS; McKenzie IF
    Immunol Rev; 1994 Oct; 141():169-90. PubMed ID: 7532618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of alpha-gal epitopes on ovarian carcinoma membranes to be used as a novel autologous tumor vaccine.
    Galili U; Chen ZC; DeGeest K
    Gynecol Oncol; 2003 Jul; 90(1):100-8. PubMed ID: 12821349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of alpha-Gal epitope derivatives with a galactosyltransferase-epimerase fusion enzyme.
    Fang J; Chen X; Zhang W; Janczuk A; Wang PG
    Carbohydr Res; 2000 Dec; 329(4):873-8. PubMed ID: 11125830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential host-dependent expression of alpha-galactosyl epitopes on viral glycoproteins: a study of eastern equine encephalitis virus as a model.
    Repik PM; Strizki JM; Galili U
    J Gen Virol; 1994 May; 75 ( Pt 5)():1177-81. PubMed ID: 7513744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pattern of anti-carbohydrate antibody responses present in patients with advanced atherosclerosis.
    Mosedale DE; Chauhan A; Schofield PM; Grainger DJ
    J Immunol Methods; 2006 Feb; 309(1-2):182-91. PubMed ID: 16442559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific stimulation of Graves' disease thyrocytes by the natural anti-Gal antibody from normal and autologous serum.
    Winand RJ; Devigne JW; Meurisse M; Galili U
    J Immunol; 1994 Aug; 153(3):1386-95. PubMed ID: 8027563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of α-galactosyl epitopes by metabolically engineered Escherichia coli.
    Gebus C; Cottin C; Randriantsoa M; Drouillard S; Samain E
    Carbohydr Res; 2012 Nov; 361():83-90. PubMed ID: 23000215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.